THCT · As filed with the SEC
THC Therapeutics balance sheet, by fiscal year
The statement as THC Therapeutics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD
| USD | FY2024 Jul 31, 2024 | FY2023 Jul 31, 2023 | FY2022 Jul 31, 2022 | FY2021 Jul 31, 2021 | FY2020 Jul 31, 2020 | Jul 31, 2019 Jul 31, 2019 | FY2013 Jul 31, 2013 | FY2012 Jul 31, 2012 |
|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||
| Cash and Cash Equivalents | — | — | — | — | — | — | 15,200 | 56,446 |
| Cash and Cash Equivalents | — | 10 | — | — | — | — | — | — |
| Cash | 35 | — | 32 | 296,130 | 43,239 | 317,551 | — | — |
| Prepaid Expenses | 0 | 970 | 40,656 | 4,586 | 0 | 140,250 | 484 | 13,947 |
| Deferred financing costs, net of amortization of $2,917 | — | — | — | — | — | — | 2,083 | — |
| Inventory | — | 0 | 25 | 830 | — | — | — | — |
| Total current assets | 35 | 980 | 40,713 | 301,546 | 43,239 | 457,801 | 17,767 | 70,393 |
| License agreement | — | — | — | — | — | — | — | 525,000 |
| Goodwill | — | — | — | — | — | — | 175,000 | — |
| Physical silver assets | — | — | — | 152,785 | — | — | — | — |
| Physical silver assets | — | — | 152,785 | — | — | — | — | — |
| Property, Plant and Equipment | — | — | 0 | 9,480 | 21,446 | 37,143 | — | — |
| Physical silver assets | — | 0 | — | — | — | — | — | — |
| Intangible Assets | — | 12,010 | 13,403 | 16,257 | 20,661 | 25,078 | — | — |
| Intangible Assets | 10,613 | — | — | — | — | — | — | — |
| Total assets | 10,648 | 12,990 | 206,901 | 480,068 | 85,346 | 520,022 | 192,767 | 595,393 |
| Current liabilities | ||||||||
| Other Current Liabilities | — | — | — | — | — | — | 65,204 | 39,381 |
| Accrued interest - related party | — | — | — | — | — | — | — | 0 |
| Short-Term Debt | — | — | — | — | — | — | — | 0 |
| Other Current Liabilities | — | — | — | — | — | — | 2,082 | — |
| Short-Term Debt | — | — | — | — | — | — | 50,000 | — |
| Short-Term Debt | — | — | — | — | — | — | 7,983 | — |
| Accounts Payable | 1,319,294 | 1,936,637 | 1,580,689 | 485,010 | 499,249 | 158,735 | — | — |
| Accounts Payable | — | — | 16,807 | 513,512 | 8,474 | 217,656 | — | — |
| Advances from related parties | — | — | — | 96,313 | 83,660 | 104,219 | — | — |
| Accrued expenses - related party | — | 5,180 | — | — | — | — | — | — |
| Accounts payable and accrued liabilities - related party | 1,001,001 | — | — | — | — | — | — | — |
| Advances from related parties | 145,106 | 59,648 | 144,632 | — | — | — | — | — |
| Long-Term Debt | — | 25,000 | — | — | — | — | — | — |
| Short-Term Debt | — | 576,028 | — | 561,346 | 305,110 | 152,895 | — | — |
| Convertible Notes payable- Related party, net | — | — | — | 200,000 | 124,931 | 24,658 | — | — |
| Other Non-Operating Current Liabilities | — | — | — | 1,001,213 | 842,573 | 611,265 | — | — |
| Short-Term Debt | 25,000 | — | 25,000 | — | — | — | — | — |
| Short-Term Debt | 576,028 | — | 576,028 | — | — | — | — | — |
| Convertible notes payable- related party | — | — | 200,000 | — | — | — | — | — |
| Convertible notes payable, related party | 130,761 | 130,761 | — | — | — | — | — | — |
| Other Non-Operating Current Liabilities | 615,013 | 489,569 | 673,712 | — | — | — | 20,445 | — |
| License fee payable | — | — | — | — | — | — | 0 | 175,000 |
| Total current liabilities | 3,812,203 | 3,222,823 | 3,216,868 | 2,857,394 | 1,863,997 | 1,269,428 | 145,714 | 214,381 |
| License fee payable, net of current portion | — | — | — | — | — | — | — | 175,000 |
| Total liabilities | 3,812,203 | 3,222,823 | 3,216,868 | 2,857,394 | 1,863,997 | 1,269,428 | 145,714 | 389,381 |
| Commitments and Contingencies (See note 10) | 0 | 100,000 | 100,000 | 100,000 | — | — | — | — |
| Stockholders' deficit | ||||||||
| Preferred Stock | — | — | — | — | 0 | 0 | — | — |
| Preferred A stock | — | — | — | — | 218 | 217 | — | — |
| Preferred A Stock | — | — | — | 218 | — | — | — | — |
| Preferred B stock | — | — | — | 0 | 0 | 0 | — | — |
| Preferred C Stock | — | — | — | 0 | — | — | — | — |
| Series A Preferred Stock. | — | 226 | — | — | — | — | — | — |
| Series A Preferred Stock | 826 | — | 226 | — | — | — | — | — |
| Series B Preferred Stock | 0 | 0 | 0 | — | — | — | — | — |
| Series C Preferred Stock | 0 | 0 | 0 | — | — | — | — | — |
| Total Stockholders' Equity | 40,266 | 32,746 | 32,492 | 29,287 | 21,462 | 14,434 | 74,037 | 63,037 |
| Stock payable | — | 752,228 | 622,278 | 658,892 | 221,700 | 417,469 | — | — |
| Stock receivable | — | — | (6,902,000) | — | — | — | — | — |
| Stock receivable | — | (6,902,000) | — | (6,902,000) | (6,902,000) | (6,902,000) | — | — |
| Treasury stock | (97,500) | — | — | — | — | — | — | — |
| Stock payable | 486,228 | — | — | — | — | — | — | — |
| Stock receivable | (6,902,000) | — | — | — | — | — | — | — |
| Additional Paid-In Capital | 41,906,132 | 41,230,912 | 41,173,946 | 40,254,257 | 39,506,284 | 38,421,610 | 1,701,489 | 282,489 |
| Stock warrants | — | — | — | — | — | — | — | 249,409 |
| Warranty and Other Provisions | — | — | — | — | — | — | 249,409 | — |
| Deferred stock-based compensation | — | — | — | — | — | — | (455,833) | — |
| Deficit accumulated during the development stage | — | — | — | — | — | — | (1,522,049) | (388,923) |
| Retained Earnings | (39,235,507) | (38,423,945) | (38,036,909) | (36,517,980) | (34,626,315) | (32,701,136) | — | — |
| Total stockholders' deficit | (3,801,555) | (3,309,833) | (3,109,967) | (2,477,326) | (1,778,651) | (749,406) | 47,053 | 206,012 |
| Total liabilities and stockholders' deficit | 10,648 | 12,990 | 206,901 | 480,068 | 85,346 | 520,022 | 192,767 | 595,393 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.